Very low expression of PD-L1 in medullary thyroid carcinoma

Endocr Relat Cancer. 2017 Jun;24(6):L35-L38. doi: 10.1530/ERC-17-0104. Epub 2017 Apr 18.

Authors

Massimo Bongiovanni¹, Caterina Rebecchini¹, Chiara Saglietti¹, Jean-Luc Bulliard², Laura Marino³, Laurence de Leval¹, Gerasimos P Sykiotis⁴

Affiliations

¹ Service of Clinical PathologyLausanne University Hospital, Institute of Pathology, Lausanne, Switzerland.
² Institute of Social and Preventive MedicineLausanne University Hospital, Lausanne, Switzerland.
³ Service of EndocrinologyDiabetology and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.
⁴ Service of EndocrinologyDiabetology and Metabolism, Lausanne University Hospital, Lausanne, Switzerland gerasimos.sykiotis@chuv.ch.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
B7-H1 Antigen / antagonists & inhibitors
B7-H1 Antigen / biosynthesis*
B7-H1 Antigen / immunology
Carcinoma, Neuroendocrine / immunology
Carcinoma, Neuroendocrine / metabolism*
Carcinoma, Neuroendocrine / pathology
Carcinoma, Neuroendocrine / therapy
Female
Humans
Immunotherapy
Male
Middle Aged
Thyroid Neoplasms / immunology
Thyroid Neoplasms / metabolism*
Thyroid Neoplasms / pathology
Thyroid Neoplasms / therapy

Substances

B7-H1 Antigen
CD274 protein, human

Supplementary concepts

Thyroid cancer, medullary